Abstract
Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have